ACE2 and fatty liver disease: The concomitance of enhanced innate immune reactivity with increased availability of ACE2 receptors in a backdrop of fatty liver disease may promote viral infection, endocytosis of virus-receptor complexes, rapid cell surface ACE2 depletion, and finally metabolic decompensation and amplified inflammation.